FusionNeoAntigen Logo

Home

Download

Statistics

Examples

Help

Contact

Terms of Use

Center for Computational Systems Medicine
leaf

Fusion Gene and Fusion Protein Summary

leaf

Fusion Amino Acid Sequences (multiple BPs and multiple gene isoforms)

leaf

Fusion Protein Breakpoint Sequences - (for the Screening of the FusionNeoAntigens)

leaf

Potential FusionNeoAntigens in HLA I - (netMHCpan v4.1 + deepHLApan v1.1)

leaf

Potential FusionNeoAntigens in HLA II - (netMHCIIpan v4.1)

leaf

Fusion Breakpoint 14 AA Peptide Structure - (RoseTTAFold)

leaf

Filtering FusionNeoAntigens Through Checking the Interaction with HLAs in 3D - (Glide)

leaf

Vaccine Design for the FusionNeoAntigens (RNA/protein sequences)

leaf

Potential target of CAR-T therapy development

leaf

Information on the samples that have these potential fusion neoantigens

leaf

Fusion Protein Targeting Drugs - (Manual Curation)

leaf

Fusion Protein Related diseases - (Manual Curation)

Fusion Protein:WDR70-ADAMTS12

Fusion Gene and Fusion Protein Summary

check button Fusion gene summary
Fusion partner gene informationFusion gene name: WDR70-ADAMTS12
FusionPDB ID: 99068
FusionGDB2.0 ID: 99068
HgeneTgene
Gene symbol

WDR70

ADAMTS12

Gene ID

55100

81792

Gene nameWD repeat domain 70ADAM metallopeptidase with thrombospondin type 1 motif 12
Synonyms-PRO4389
Cytomap

5p13.2

5p13.3-p13.2

Type of geneprotein-codingprotein-coding
DescriptionWD repeat-containing protein 70A disintegrin and metalloproteinase with thrombospondin motifs 12ADAM-TS 12ADAM-TS12ADAMTS-12a disintegrin-like and metalloprotease (reprolysin type) with thrombospondin type 1 motif, 12
Modification date2020031320200313
UniProtAcc.

P58397

Main function of 5'-partner protein: FUNCTION: Metalloprotease that may play a role in the degradation of COMP. Cleaves also alpha-2 macroglobulin and aggregan. Has anti-tumorigenic properties. {ECO:0000269|PubMed:16611630, ECO:0000269|PubMed:17895370, ECO:0000269|PubMed:18485748}.
Ensembl transtripts involved in fusion geneENST idsENST00000510699, ENST00000265107, 
ENST00000504564, 
ENST00000352040, 
ENST00000504830, ENST00000504582, 
ENST00000515401, 
Fusion gene scores for assessment (based on all fusion genes of FusionGDB 2.0)* DoF score13 X 9 X 6=7029 X 7 X 7=441
# samples 139
** MAII scorelog2(13/702*10)=-2.43295940727611
possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs).
DoF>8 and MAII<0
log2(9/441*10)=-2.29278174922785
possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs).
DoF>8 and MAII<0
Fusion gene context

PubMed: WDR70 [Title/Abstract] AND ADAMTS12 [Title/Abstract] AND fusion [Title/Abstract]

Fusion neoantigen context

PubMed: WDR70 [Title/Abstract] AND ADAMTS12 [Title/Abstract] AND neoantigen [Title/Abstract]

Most frequent breakpoint (based on all fusion genes of FusionGDB 2.0)WDR70(37605340)-ADAMTS12(33751653), # samples:3
Anticipated loss of major functional domain due to fusion event.WDR70-ADAMTS12 seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF.
WDR70-ADAMTS12 seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF.
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types
** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10)

check button Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez
PartnerGeneGO IDGO termPubMed ID
TgeneADAMTS12

GO:0030167

proteoglycan catabolic process

17895370

TgeneADAMTS12

GO:0032331

negative regulation of chondrocyte differentiation

22247065

TgeneADAMTS12

GO:0050727

regulation of inflammatory response

23019333

TgeneADAMTS12

GO:0051603

proteolysis involved in cellular protein catabolic process

16611630

TgeneADAMTS12

GO:0071773

cellular response to BMP stimulus

22247065

TgeneADAMTS12

GO:1901509

regulation of endothelial tube morphogenesis

17895370

TgeneADAMTS12

GO:1902203

negative regulation of hepatocyte growth factor receptor signaling pathway

17895370

TgeneADAMTS12

GO:1902548

negative regulation of cellular response to vascular endothelial growth factor stimulus

17895370

TgeneADAMTS12

GO:2001113

negative regulation of cellular response to hepatocyte growth factor stimulus

17895370



check button Four levels of functional features of fusion genes
Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/chr5:37605340/chr5:33751653)
- FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels.
- How to search
1. Put your fusion gene symbol.
2. Press the tab key until there will be shown the breakpoint information filled.
4. Go down and press 'Search' tab twice.
4. Go down to have the hyperlink of the search result.
5. Click the hyperlink.
6. See the FGviewer result for your fusion gene.
FGviewer

check buttonRetention analysis results of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features, are available here.

check buttonFusion gene breakpoints across WDR70 (5'-gene)
* Click on the image to open the UCSC genome browser with custom track showing this image in a new window.
all structure

check buttonFusion gene breakpoints across ADAMTS12 (3'-gene)
* Click on the image to open the UCSC genome browser with custom track showing this image in a new window.
all structure


Top

Fusion Amino Acid Sequences


check buttonFusion information from ORFfinder translation from full-length transcript sequence from FusionPDB.
HenstTenstHgeneHchrHbpHstrandTgeneTchrTbpTstrandSeq length
(transcript)
BP loci
(transcript)
Predicted start
(transcript)
Predicted stop
(transcript)
Seq length
(amino acids)
ENST00000265107WDR70chr537605340+ENST00000504830ADAMTS12chr533751653-919712487855431821
ENST00000265107WDR70chr537605340+ENST00000352040ADAMTS12chr533751653-529612487852881736
ENST00000504564WDR70chr537605340+ENST00000504830ADAMTS12chr533751653-91241175554701821
ENST00000504564WDR70chr537605340+ENST00000352040ADAMTS12chr533751653-52231175552151736

check buttonDeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated.
HenstTenstHgeneHchrHbpHstrandTgeneTchrTbpTstrandNo-coding scoreCoding score
ENST00000265107ENST00000504830WDR70chr537605340+ADAMTS12chr533751653-0.0002371790.99976283
ENST00000265107ENST00000352040WDR70chr537605340+ADAMTS12chr533751653-0.0006561110.99934393
ENST00000504564ENST00000504830WDR70chr537605340+ADAMTS12chr533751653-0.0002144710.9997855
ENST00000504564ENST00000352040WDR70chr537605340+ADAMTS12chr533751653-0.0005951080.9994049

check button Predicted full-length fusion amino acid sequences. For individual full-length fusion transcript sequence from FusionPDB, we ran ORFfinder and chose the longest ORF among all the predicted ones.

Get the fusion protein sequences from here.

Fusion protein sequence information is available in the fasta format.
>FusionGDB ID_FusionGDB isoform ID_FGname_Hgene_Hchr_Hbp_Henst_Tgene_Tchr_Tbp_Tenst_length(fusion AA) seq_BP

Top

Fusion Protein Breakpoint Sequences for WDR70-ADAMTS12

check button +/-13 AA sequence from the breakpoints of the fusion protein sequences.
HgeneHchrHbpTgeneTchrTbpLength(fusion protein)BP in fusion proteinPeptide
WDR70chr537605340ADAMTS12chr5337516531175388ACQNGSIQIWDRNLTTGFFQLPHGDF
WDR70chr537605340ADAMTS12chr5337516531248388ACQNGSIQIWDRNLTTGFFQLPHGDF

Top

Potential FusionNeoAntigen Information of WDR70-ADAMTS12 in HLA I

check button Multiple sequence alignments of the potential FusionNeoAntigens per fusion breakpoints. If the MSA is empty, then it means that there were predicted fusion neoantigens in this fusion breakpoint, but those predicted fusion neoantigens were not across the breakpoint, which is not fusion-specific.
WDR70-ADAMTS12_37605340_33751653.msa

check button Potential FusionNeoAntigen Information
* We used NetMHCpan v4.1 (%rank<0.5) and deepHLApan v1.1 (immunogenic score>0.5)
Fusion geneHchrHbpTgeneTchrTbpHLA IFusionNeoAntigen peptideBinding scoreImmunogenic scoreNeoantigen start (at BP 13)Neoantigen end (at BP 13)
WDR70-ADAMTS12chr537605340chr5337516531248HLA-A02:22NLTTGFFQL0.94240.7951221
WDR70-ADAMTS12chr537605340chr5337516531248HLA-A02:24NLTTGFFQL0.9140.71631221
WDR70-ADAMTS12chr537605340chr5337516531248HLA-A02:67NLTTGFFQL0.9140.71631221
WDR70-ADAMTS12chr537605340chr5337516531248HLA-A02:30NLTTGFFQL0.9140.71631221
WDR70-ADAMTS12chr537605340chr5337516531248HLA-A02:60NLTTGFFQL0.91320.71521221
WDR70-ADAMTS12chr537605340chr5337516531248HLA-A02:11NLTTGFFQL0.91240.73511221
WDR70-ADAMTS12chr537605340chr5337516531248HLA-A02:16NLTTGFFQL0.88530.60041221
WDR70-ADAMTS12chr537605340chr5337516531248HLA-A02:29NLTTGFFQL0.84040.71631221
WDR70-ADAMTS12chr537605340chr5337516531248HLA-A02:04NLTTGFFQL0.83730.85021221
WDR70-ADAMTS12chr537605340chr5337516531248HLA-A02:27NLTTGFFQL0.83350.77291221
WDR70-ADAMTS12chr537605340chr5337516531248HLA-A02:17NLTTGFFQL0.81890.87151221
WDR70-ADAMTS12chr537605340chr5337516531248HLA-A02:19NLTTGFFQL0.74750.81481221
WDR70-ADAMTS12chr537605340chr5337516531248HLA-B15:18DRNLTTGFF0.23630.541019
WDR70-ADAMTS12chr537605340chr5337516531248HLA-A24:23IWDRNLTTGF0.99190.7236818
WDR70-ADAMTS12chr537605340chr5337516531248HLA-A24:25IWDRNLTTGF0.99140.8653818
WDR70-ADAMTS12chr537605340chr5337516531248HLA-A23:05IWDRNLTTGF0.99120.6111818
WDR70-ADAMTS12chr537605340chr5337516531248HLA-A24:10IWDRNLTTGF0.98960.5958818
WDR70-ADAMTS12chr537605340chr5337516531248HLA-A24:20IWDRNLTTGF0.9890.8642818
WDR70-ADAMTS12chr537605340chr5337516531248HLA-A24:15IWDRNLTTGF0.98830.8616818
WDR70-ADAMTS12chr537605340chr5337516531248HLA-A23:04IWDRNLTTGF0.98730.5338818
WDR70-ADAMTS12chr537605340chr5337516531248HLA-A24:31IWDRNLTTGF0.98440.8696818
WDR70-ADAMTS12chr537605340chr5337516531248HLA-A24:17IWDRNLTTGF0.97340.8672818
WDR70-ADAMTS12chr537605340chr5337516531248HLA-A24:14IWDRNLTTGF0.86790.7762818
WDR70-ADAMTS12chr537605340chr5337516531248HLA-A32:13QIWDRNLTTGF0.98840.996718
WDR70-ADAMTS12chr537605340chr5337516531248HLA-A02:02NLTTGFFQL0.94530.69291221
WDR70-ADAMTS12chr537605340chr5337516531248HLA-A02:05NLTTGFFQL0.93740.76241221
WDR70-ADAMTS12chr537605340chr5337516531248HLA-A02:07NLTTGFFQL0.91760.7771221
WDR70-ADAMTS12chr537605340chr5337516531248HLA-A02:01NLTTGFFQL0.9140.71631221
WDR70-ADAMTS12chr537605340chr5337516531248HLA-C04:07IWDRNLTTGF0.99970.8772818
WDR70-ADAMTS12chr537605340chr5337516531248HLA-C04:10IWDRNLTTGF0.99970.8712818
WDR70-ADAMTS12chr537605340chr5337516531248HLA-A23:01IWDRNLTTGF0.98960.608818
WDR70-ADAMTS12chr537605340chr5337516531248HLA-A24:02IWDRNLTTGF0.9890.8642818
WDR70-ADAMTS12chr537605340chr5337516531248HLA-C04:14IWDRNLTTGF0.97510.8381818
WDR70-ADAMTS12chr537605340chr5337516531248HLA-A02:14NLTTGFFQL0.89690.7421221
WDR70-ADAMTS12chr537605340chr5337516531248HLA-C04:01IWDRNLTTGF0.99970.8772818
WDR70-ADAMTS12chr537605340chr5337516531248HLA-C18:01IWDRNLTTGF0.99950.873818
WDR70-ADAMTS12chr537605340chr5337516531248HLA-A24:03IWDRNLTTGF0.99190.7236818

Top

Potential FusionNeoAntigen Information of WDR70-ADAMTS12 in HLA II

check button Multiple sequence alignments of the potential FusionNeoAntigens per fusion breakpoints. If the MSA is empty, then it means that there were predicted fusion neoantigens in this fusion breakpoint, but those predicted fusion neoantigens were not across the breakpoint, which is not fusion-specific.
WDR70-ADAMTS12_37605340_33751653.msa

check button Potential FusionNeoAntigen Information
* We used NetMHCIIpan v4.1 (%rank<0.5).
Fusion geneHchrHbpTgeneTchrTbpHLA IIFusionNeoAntigen peptideNeoantigen start (at BP 13)Neoantigen end (at BP 13)
WDR70-ADAMTS12chr537605340chr5337516531248DRB1-1102QNGSIQIWDRNLTTG217
WDR70-ADAMTS12chr537605340chr5337516531248DRB1-1102NGSIQIWDRNLTTGF318
WDR70-ADAMTS12chr537605340chr5337516531248DRB1-1103QNGSIQIWDRNLTTG217
WDR70-ADAMTS12chr537605340chr5337516531248DRB1-1103NGSIQIWDRNLTTGF318
WDR70-ADAMTS12chr537605340chr5337516531248DRB1-1116QNGSIQIWDRNLTTG217
WDR70-ADAMTS12chr537605340chr5337516531248DRB1-1116NGSIQIWDRNLTTGF318
WDR70-ADAMTS12chr537605340chr5337516531248DRB1-1121NGSIQIWDRNLTTGF318
WDR70-ADAMTS12chr537605340chr5337516531248DRB1-1121QNGSIQIWDRNLTTG217
WDR70-ADAMTS12chr537605340chr5337516531248DRB1-1136QNGSIQIWDRNLTTG217
WDR70-ADAMTS12chr537605340chr5337516531248DRB1-1136NGSIQIWDRNLTTGF318
WDR70-ADAMTS12chr537605340chr5337516531248DRB1-1141QNGSIQIWDRNLTTG217
WDR70-ADAMTS12chr537605340chr5337516531248DRB1-1141NGSIQIWDRNLTTGF318
WDR70-ADAMTS12chr537605340chr5337516531248DRB1-1148QNGSIQIWDRNLTTG217
WDR70-ADAMTS12chr537605340chr5337516531248DRB1-1148NGSIQIWDRNLTTGF318
WDR70-ADAMTS12chr537605340chr5337516531248DRB1-1148CQNGSIQIWDRNLTT116
WDR70-ADAMTS12chr537605340chr5337516531248DRB1-1155QNGSIQIWDRNLTTG217
WDR70-ADAMTS12chr537605340chr5337516531248DRB1-1155NGSIQIWDRNLTTGF318
WDR70-ADAMTS12chr537605340chr5337516531248DRB1-1159QNGSIQIWDRNLTTG217
WDR70-ADAMTS12chr537605340chr5337516531248DRB1-1159NGSIQIWDRNLTTGF318
WDR70-ADAMTS12chr537605340chr5337516531248DRB1-1163QNGSIQIWDRNLTTG217
WDR70-ADAMTS12chr537605340chr5337516531248DRB1-1163NGSIQIWDRNLTTGF318
WDR70-ADAMTS12chr537605340chr5337516531248DRB1-1165QNGSIQIWDRNLTTG217
WDR70-ADAMTS12chr537605340chr5337516531248DRB1-1165NGSIQIWDRNLTTGF318
WDR70-ADAMTS12chr537605340chr5337516531248DRB1-1169QNGSIQIWDRNLTTG217
WDR70-ADAMTS12chr537605340chr5337516531248DRB1-1170NGSIQIWDRNLTTGF318
WDR70-ADAMTS12chr537605340chr5337516531248DRB1-1170QNGSIQIWDRNLTTG217
WDR70-ADAMTS12chr537605340chr5337516531248DRB1-1176QNGSIQIWDRNLTTG217
WDR70-ADAMTS12chr537605340chr5337516531248DRB1-1176NGSIQIWDRNLTTGF318
WDR70-ADAMTS12chr537605340chr5337516531248DRB1-1182QNGSIQIWDRNLTTG217
WDR70-ADAMTS12chr537605340chr5337516531248DRB1-1182NGSIQIWDRNLTTGF318
WDR70-ADAMTS12chr537605340chr5337516531248DRB1-1185QNGSIQIWDRNLTTG217
WDR70-ADAMTS12chr537605340chr5337516531248DRB1-1185NGSIQIWDRNLTTGF318
WDR70-ADAMTS12chr537605340chr5337516531248DRB1-1301QNGSIQIWDRNLTTG217
WDR70-ADAMTS12chr537605340chr5337516531248DRB1-1301NGSIQIWDRNLTTGF318
WDR70-ADAMTS12chr537605340chr5337516531248DRB1-1304QNGSIQIWDRNLTTG217
WDR70-ADAMTS12chr537605340chr5337516531248DRB1-1304NGSIQIWDRNLTTGF318
WDR70-ADAMTS12chr537605340chr5337516531248DRB1-1304CQNGSIQIWDRNLTT116
WDR70-ADAMTS12chr537605340chr5337516531248DRB1-1308QNGSIQIWDRNLTTG217
WDR70-ADAMTS12chr537605340chr5337516531248DRB1-1308NGSIQIWDRNLTTGF318
WDR70-ADAMTS12chr537605340chr5337516531248DRB1-1308CQNGSIQIWDRNLTT116
WDR70-ADAMTS12chr537605340chr5337516531248DRB1-1309QNGSIQIWDRNLTTG217
WDR70-ADAMTS12chr537605340chr5337516531248DRB1-1309NGSIQIWDRNLTTGF318
WDR70-ADAMTS12chr537605340chr5337516531248DRB1-1309CQNGSIQIWDRNLTT116
WDR70-ADAMTS12chr537605340chr5337516531248DRB1-1309GSIQIWDRNLTTGFF419
WDR70-ADAMTS12chr537605340chr5337516531248DRB1-1315NGSIQIWDRNLTTGF318
WDR70-ADAMTS12chr537605340chr5337516531248DRB1-1315QNGSIQIWDRNLTTG217
WDR70-ADAMTS12chr537605340chr5337516531248DRB1-1317QNGSIQIWDRNLTTG217
WDR70-ADAMTS12chr537605340chr5337516531248DRB1-1317NGSIQIWDRNLTTGF318
WDR70-ADAMTS12chr537605340chr5337516531248DRB1-1319QNGSIQIWDRNLTTG217
WDR70-ADAMTS12chr537605340chr5337516531248DRB1-1319NGSIQIWDRNLTTGF318
WDR70-ADAMTS12chr537605340chr5337516531248DRB1-1320QNGSIQIWDRNLTTG217
WDR70-ADAMTS12chr537605340chr5337516531248DRB1-1320NGSIQIWDRNLTTGF318
WDR70-ADAMTS12chr537605340chr5337516531248DRB1-1322QNGSIQIWDRNLTTG217
WDR70-ADAMTS12chr537605340chr5337516531248DRB1-1322NGSIQIWDRNLTTGF318
WDR70-ADAMTS12chr537605340chr5337516531248DRB1-1324QNGSIQIWDRNLTTG217
WDR70-ADAMTS12chr537605340chr5337516531248DRB1-1324NGSIQIWDRNLTTGF318
WDR70-ADAMTS12chr537605340chr5337516531248DRB1-1327QNGSIQIWDRNLTTG217
WDR70-ADAMTS12chr537605340chr5337516531248DRB1-1327NGSIQIWDRNLTTGF318
WDR70-ADAMTS12chr537605340chr5337516531248DRB1-1332QNGSIQIWDRNLTTG217
WDR70-ADAMTS12chr537605340chr5337516531248DRB1-1332NGSIQIWDRNLTTGF318
WDR70-ADAMTS12chr537605340chr5337516531248DRB1-1332CQNGSIQIWDRNLTT116
WDR70-ADAMTS12chr537605340chr5337516531248DRB1-1335QNGSIQIWDRNLTTG217
WDR70-ADAMTS12chr537605340chr5337516531248DRB1-1335NGSIQIWDRNLTTGF318
WDR70-ADAMTS12chr537605340chr5337516531248DRB1-1336QNGSIQIWDRNLTTG217
WDR70-ADAMTS12chr537605340chr5337516531248DRB1-1336NGSIQIWDRNLTTGF318
WDR70-ADAMTS12chr537605340chr5337516531248DRB1-1343QNGSIQIWDRNLTTG217
WDR70-ADAMTS12chr537605340chr5337516531248DRB1-1343NGSIQIWDRNLTTGF318
WDR70-ADAMTS12chr537605340chr5337516531248DRB1-1348QNGSIQIWDRNLTTG217
WDR70-ADAMTS12chr537605340chr5337516531248DRB1-1348NGSIQIWDRNLTTGF318
WDR70-ADAMTS12chr537605340chr5337516531248DRB1-1348CQNGSIQIWDRNLTT116
WDR70-ADAMTS12chr537605340chr5337516531248DRB1-1351QNGSIQIWDRNLTTG217
WDR70-ADAMTS12chr537605340chr5337516531248DRB1-1351NGSIQIWDRNLTTGF318
WDR70-ADAMTS12chr537605340chr5337516531248DRB1-1352QNGSIQIWDRNLTTG217
WDR70-ADAMTS12chr537605340chr5337516531248DRB1-1352NGSIQIWDRNLTTGF318
WDR70-ADAMTS12chr537605340chr5337516531248DRB1-1353QNGSIQIWDRNLTTG217
WDR70-ADAMTS12chr537605340chr5337516531248DRB1-1353NGSIQIWDRNLTTGF318
WDR70-ADAMTS12chr537605340chr5337516531248DRB1-1354QNGSIQIWDRNLTTG217
WDR70-ADAMTS12chr537605340chr5337516531248DRB1-1354NGSIQIWDRNLTTGF318
WDR70-ADAMTS12chr537605340chr5337516531248DRB1-1357NGSIQIWDRNLTTGF318
WDR70-ADAMTS12chr537605340chr5337516531248DRB1-1357QNGSIQIWDRNLTTG217
WDR70-ADAMTS12chr537605340chr5337516531248DRB1-1359QNGSIQIWDRNLTTG217
WDR70-ADAMTS12chr537605340chr5337516531248DRB1-1359NGSIQIWDRNLTTGF318
WDR70-ADAMTS12chr537605340chr5337516531248DRB1-1361NGSIQIWDRNLTTGF318
WDR70-ADAMTS12chr537605340chr5337516531248DRB1-1361QNGSIQIWDRNLTTG217
WDR70-ADAMTS12chr537605340chr5337516531248DRB1-1364QNGSIQIWDRNLTTG217
WDR70-ADAMTS12chr537605340chr5337516531248DRB1-1364NGSIQIWDRNLTTGF318
WDR70-ADAMTS12chr537605340chr5337516531248DRB1-1368QNGSIQIWDRNLTTG217
WDR70-ADAMTS12chr537605340chr5337516531248DRB1-1368NGSIQIWDRNLTTGF318
WDR70-ADAMTS12chr537605340chr5337516531248DRB1-1369QNGSIQIWDRNLTTG217
WDR70-ADAMTS12chr537605340chr5337516531248DRB1-1369NGSIQIWDRNLTTGF318
WDR70-ADAMTS12chr537605340chr5337516531248DRB1-1370QNGSIQIWDRNLTTG217
WDR70-ADAMTS12chr537605340chr5337516531248DRB1-1370NGSIQIWDRNLTTGF318
WDR70-ADAMTS12chr537605340chr5337516531248DRB1-1370CQNGSIQIWDRNLTT116
WDR70-ADAMTS12chr537605340chr5337516531248DRB1-1371QNGSIQIWDRNLTTG217
WDR70-ADAMTS12chr537605340chr5337516531248DRB1-1371NGSIQIWDRNLTTGF318
WDR70-ADAMTS12chr537605340chr5337516531248DRB1-1372QNGSIQIWDRNLTTG217
WDR70-ADAMTS12chr537605340chr5337516531248DRB1-1372NGSIQIWDRNLTTGF318
WDR70-ADAMTS12chr537605340chr5337516531248DRB1-1372CQNGSIQIWDRNLTT116
WDR70-ADAMTS12chr537605340chr5337516531248DRB1-1375QNGSIQIWDRNLTTG217
WDR70-ADAMTS12chr537605340chr5337516531248DRB1-1375NGSIQIWDRNLTTGF318
WDR70-ADAMTS12chr537605340chr5337516531248DRB1-1376QNGSIQIWDRNLTTG217
WDR70-ADAMTS12chr537605340chr5337516531248DRB1-1376NGSIQIWDRNLTTGF318
WDR70-ADAMTS12chr537605340chr5337516531248DRB1-1378QNGSIQIWDRNLTTG217
WDR70-ADAMTS12chr537605340chr5337516531248DRB1-1378NGSIQIWDRNLTTGF318
WDR70-ADAMTS12chr537605340chr5337516531248DRB1-1379QNGSIQIWDRNLTTG217
WDR70-ADAMTS12chr537605340chr5337516531248DRB1-1379NGSIQIWDRNLTTGF318
WDR70-ADAMTS12chr537605340chr5337516531248DRB1-1380QNGSIQIWDRNLTTG217
WDR70-ADAMTS12chr537605340chr5337516531248DRB1-1380NGSIQIWDRNLTTGF318
WDR70-ADAMTS12chr537605340chr5337516531248DRB1-1383QNGSIQIWDRNLTTG217
WDR70-ADAMTS12chr537605340chr5337516531248DRB1-1383NGSIQIWDRNLTTGF318
WDR70-ADAMTS12chr537605340chr5337516531248DRB1-1384QNGSIQIWDRNLTTG217
WDR70-ADAMTS12chr537605340chr5337516531248DRB1-1384NGSIQIWDRNLTTGF318
WDR70-ADAMTS12chr537605340chr5337516531248DRB1-1384CQNGSIQIWDRNLTT116
WDR70-ADAMTS12chr537605340chr5337516531248DRB1-1387QNGSIQIWDRNLTTG217
WDR70-ADAMTS12chr537605340chr5337516531248DRB1-1387NGSIQIWDRNLTTGF318
WDR70-ADAMTS12chr537605340chr5337516531248DRB1-1391QNGSIQIWDRNLTTG217
WDR70-ADAMTS12chr537605340chr5337516531248DRB1-1391NGSIQIWDRNLTTGF318
WDR70-ADAMTS12chr537605340chr5337516531248DRB1-1392QNGSIQIWDRNLTTG217
WDR70-ADAMTS12chr537605340chr5337516531248DRB1-1392NGSIQIWDRNLTTGF318
WDR70-ADAMTS12chr537605340chr5337516531248DRB1-1393QNGSIQIWDRNLTTG217
WDR70-ADAMTS12chr537605340chr5337516531248DRB1-1393NGSIQIWDRNLTTGF318
WDR70-ADAMTS12chr537605340chr5337516531248DRB1-1393CQNGSIQIWDRNLTT116
WDR70-ADAMTS12chr537605340chr5337516531248DRB1-1398QNGSIQIWDRNLTTG217
WDR70-ADAMTS12chr537605340chr5337516531248DRB1-1398NGSIQIWDRNLTTGF318
WDR70-ADAMTS12chr537605340chr5337516531248DRB1-1416QNGSIQIWDRNLTTG217
WDR70-ADAMTS12chr537605340chr5337516531248DRB1-1416NGSIQIWDRNLTTGF318
WDR70-ADAMTS12chr537605340chr5337516531248DRB1-1416CQNGSIQIWDRNLTT116
WDR70-ADAMTS12chr537605340chr5337516531248DRB1-1437QNGSIQIWDRNLTTG217
WDR70-ADAMTS12chr537605340chr5337516531248DRB1-1437NGSIQIWDRNLTTGF318
WDR70-ADAMTS12chr537605340chr5337516531248DRB1-1437CQNGSIQIWDRNLTT116

Top

Fusion breakpoint peptide structures of WDR70-ADAMTS12

check button3D structures of the fusion breakpoint peptide of 14AA sequence that have potential fusion neoantigens
* The minimum length of the amino acid sequence in RoseTTAFold is 14AA. Here, we predicted the 14AA fusion protein breakpoint sequence not the fusion neoantigen peptide, which is shorter than 14 AA.
File nameBPseqHgeneTgeneHchrHbpTchrTbpAAlen
3916IQIWDRNLTTGFFQWDR70ADAMTS12chr537605340chr5337516531248

Top

Filtering FusionNeoAntigens Through Checking the Interaction with HLAs in 3D of WDR70-ADAMTS12

check buttonVirtual screening between 25 HLAs (from PDB) and FusionNeoAntigens
* We used Glide to predict the interaction between HLAs and neoantigens.
HLA allelePDB IDFile nameBPseqDocking scoreGlide score
HLA-B14:023BVN3916IQIWDRNLTTGFFQ-7.15543-7.26883
HLA-B14:023BVN3916IQIWDRNLTTGFFQ-4.77435-5.80965
HLA-B52:013W393916IQIWDRNLTTGFFQ-6.80875-6.92215
HLA-B52:013W393916IQIWDRNLTTGFFQ-4.20386-5.23916
HLA-A11:014UQ23916IQIWDRNLTTGFFQ-7.5194-8.5547
HLA-A11:014UQ23916IQIWDRNLTTGFFQ-6.9601-7.0735
HLA-A24:025HGA3916IQIWDRNLTTGFFQ-7.52403-7.63743
HLA-A24:025HGA3916IQIWDRNLTTGFFQ-5.82433-6.85963
HLA-B27:056PYJ3916IQIWDRNLTTGFFQ-3.28285-4.31815
HLA-B44:053DX83916IQIWDRNLTTGFFQ-5.91172-6.94702
HLA-B44:053DX83916IQIWDRNLTTGFFQ-4.24346-4.35686

Top

Vaccine Design for the FusionNeoAntigens of WDR70-ADAMTS12

check button mRNA and peptide sequences of FusionNeoAntigens that have potential interaction with HLA-Is.
Fusion geneHchrHbpTchrTbpStart in +/-13AAEnd in +/-13AAFusionNeoAntigen peptide sequenceFusionNeoAntigen RNA sequence
WDR70-ADAMTS12chr537605340chr5337516531019DRNLTTGFFAATTTGACTACTGGATTTTTCCAACTA
WDR70-ADAMTS12chr537605340chr5337516531221NLTTGFFQLACTACTGGATTTTTCCAACTACCACAT
WDR70-ADAMTS12chr537605340chr533751653718QIWDRNLTTGFTGGGACCGAAATTTGACTACTGGATTTTTCCAA
WDR70-ADAMTS12chr537605340chr533751653818IWDRNLTTGFGACCGAAATTTGACTACTGGATTTTTCCAA

check button mRNA and peptide sequences of FusionNeoAntigens that have potential interaction with HLA-IIs.
Fusion geneHchrHbpTchrTbpStart in +/-13AAEnd in +/-13AAFusionNeoAntigen peptideFusionNEoAntigen RNA sequence
WDR70-ADAMTS12chr537605340chr533751653116CQNGSIQIWDRNLTTAATGGAAGCATACAGATCTGGGACCGAAATTTGACTACTGGATTT
WDR70-ADAMTS12chr537605340chr533751653217QNGSIQIWDRNLTTGGGAAGCATACAGATCTGGGACCGAAATTTGACTACTGGATTTTTC
WDR70-ADAMTS12chr537605340chr533751653318NGSIQIWDRNLTTGFAGCATACAGATCTGGGACCGAAATTTGACTACTGGATTTTTCCAA
WDR70-ADAMTS12chr537605340chr533751653419GSIQIWDRNLTTGFFATACAGATCTGGGACCGAAATTTGACTACTGGATTTTTCCAACTA

Top

Information of the samples that have these potential fusion neoantigens of WDR70-ADAMTS12

check button These samples were reported as having these fusion breakpoints. For individual breakpoints, we checked the open reading frames considering multiple gene isoforms and chose the in-frame fusion genes only. Then, we made fusion protein sequences and predicted the fusion neoantigens. These fusion-positive samples may have these potential fusion neoantigens.
Cancer typeFusion geneHchrHbpHenstTchrTbpTenstSample
BRCAWDR70-ADAMTS12chr537605340ENST00000265107chr533751653ENST00000352040TCGA-A2-A0SY-01A

Top

Potential target of CAR-T therapy development for WDR70-ADAMTS12

check button Predicted 3D structure. We used RoseTTAFold.

check buttonRetention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, to provide the retention of the transmembrane domain, we only show the protein feature retention information of those transmembrane features


* Minus value of BPloci means that the break point is located before the CDS.
- In-frame and retained 'Transmembrane'.
PartnerGeneHbpTbpENSTStrandBPexonTotalExonProtein feature loci*BPlociTotalLenProtein featureProtein feature note

check button Subcellular localization prediction of the transmembrane domain retained fusion proteins
* We used DeepLoc 1.0. The order of the X-axis of the barplot is as follows: Entry_ID, Localization, Type, Nucleus, Cytoplasm, Extracellular, Mitochondrion, Cell_membrane, Endoplasmic_reticulum, Plastid, Golgi.apparatus, Lysosome.Vacuole, Peroxisome. Y-axis is the output score of DeepLoc. Clicking the image will open a new tab with a large image.
HgeneHchrHbpHenstTgeneTchrTbpTenstDeepLoc result

Top

Related Drugs to WDR70-ADAMTS12

check button Drugs used for this fusion-positive patient.
(Manual curation of PubMed, 04-30-2022 + MyCancerGenome)
HgeneTgeneDrugSourcePMID

Top

Related Diseases to WDR70-ADAMTS12

check button Diseases that have this fusion gene.
(Manual curation of PubMed, 04-30-2022 + MyCancerGenome)
HgeneTgeneDiseaseSourcePMID

check button Diseases associated with fusion partners.
(DisGeNet 4.0)
PartnerGeneDisease IDDisease name# pubmedsSource